Navigation Links
Suneva Medical to Pursue Expanded Indications for Artefill® With Launch of Phase III Acne Scar Study

SAN DIEGO, Jan. 11, 2012 /PRNewswire/ -- Suneva Medical, a privately-held aesthetic medical device company, today announced that it is launching a multi-center study to investigate the efficacy of Artefill for the treatment of acne scars. The 150-patient prospective study is being conducted at 10 centers throughout the U.S. and will enroll its first patient by February.  

"Acne can have lasting effects on a patient's self-esteem, especially when we are limited in our ability to permanently treat the resulting scars," said study investigator Ava Shamban, M.D. "Artefill is a great solution for my regular filler patients who want to correct facial wrinkles with natural, long-lasting results and we are optimistic about its effectiveness with this new patient population."

According to the American Dermatology Association, acne is the most common skin disorder in the United States, affecting 40 million to 50 million Americans. By mid-teens, more than 40 percent of adolescents have acne or acne scarring, which requires treatment by a dermatologist. Studies have reported the incidence of acne scarring in the general population to be 1 to 11 percent[1].

"Acne scarring impacts patients both physically and emotionally as it's a direct reminder of the issues that affected them during their earlier years.  However, there is no permanent solution on the market today to address this widespread cosmetic issue. We believe Artefill's unique composition may provide these patients a real solution for what many thought would be a lifelong problem," commented Nicholas Teti, Chairman and CEO of Suneva Medical. He continued, "We are pleased to be working with a strong and prominent group of investigators on this trial as we look to expand the indications for Artefill."

Approved in 2006, Artefill is a long-lasting, dermal filler. It is composed of bovine collagen and unique microspheres and includes lidocaine for improved patient comfort. This distinct formulation offers patients long-lasting wrinkle correction. To date over 30,000 patients have been treated.

Patients interested in additional information about this trial may visit

About Suneva Medical

Suneva Medical, Inc. is a medical technology company focused on developing, manufacturing and commercializing novel, differentiated aesthetic products for the dermatology, plastic and cosmetic surgery markets. The Company's long-lasting injectable product is marketed as Artefill® in the U.S. and Bellafill™ in Canada to correct facial wrinkles. For more information visit or

[1] Cunliffe WJ, Gould DJ. Prevalence of facial acne vulgaris in late adolescence and in adults. Br Med J. 1979;1(6171): 1109–1110. Goulden V, Stables GI, Cunliffe WJ. Prevalence of facial acne in adults. J Am Acad Dermatol. 1999:41:577–580.

Kate Gilbert 
Vice President, Marketing 
Suneva Medical 
(858) 550-9999 x7844 
Kellie Walsh 
(914) 315-6072

SOURCE Suneva Medical
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Suneva Medical Signs Multi-Million Dollar Line of Credit Agreement with Western Technology Investment
2. Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer
3. Suneva Medical Announces Canadian Approval of Bellafill™
4. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
5. You May Have a Thyroid Problem and Not Know It - Particularly If Youre Over 60, Says a New Harvard Medical School Report
6. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
7. Globus Medical Raises $110 Million in Series E Financing Round
8. Quark Pharmaceuticals Appoints New Chief Medical Officer
9. Boston University Biomedical Engineers Find Chink in Bacterias Armor
10. Rochester Medical Anti-Infection Foley Catheter Demonstrates Effectiveness in Randomized Trial
11. Rockwell Medical Technologies, Inc. Begins Patient Enrollment for its SFP Dose-Ranging Study
Post Your Comments:
(Date:11/24/2015)... , November 25, 2015 ... due to repeated failure of IVF cycles. After failure ... was totally dejected and had lost all hopes that she would be able ... Indian miracle child conceived after failure of over 15 ... abroad (UK) before they decided to take one last attempt with ...
(Date:11/24/2015)... SAN CARLOS, Calif. , Nov. 24, ... ), a leader in non-invasive genetic testing ... today announced that it will present at ... Conference in New York on Wednesday, December 2, 2015 at 1:00 p.m. ... discuss the Company,s financial results, business activities ...
(Date:11/24/2015)... /PRNewswire/ - ESSA Pharma Inc. ("ESSA" or the "Company") ... the first patient has been enrolled in ESSA,s Phase ... metastatic castration-resistant prostate cancer ("mCRPC"). the ... the United States and Canada.  ... trial, ESSA intends to demonstrate the safety, tolerability, maximum ...
Breaking Medicine Technology:
(Date:11/25/2015)... , ... November 25, 2015 , ... On November 10, ... States District Court of Connecticut on behalf of a home health care worker who ... current or former home health care workers employed by Humana, Inc., Humana at Home, ...
(Date:11/25/2015)... ... , ... On November 25, 2015, officials of Narconon Arrowhead , the ... of a new cutting edge recovery program that has been 50 years in the ... alcohol-addicted individuals with the purpose to free addicts from the symptoms and negative behaviors ...
(Date:11/25/2015)... ... , ... SCOTTSDALE, AZ) - Today, Dr. Todd C. ... and non-surgical treatments, announced the expansion of his private practice capabilities with the ... Highly trained and nationally recognized for his natural approach, Dr. Todd Hobgood serves ...
(Date:11/25/2015)... (PRWEB) , ... November 25, 2015 , ... Today, ... on our nation’s roadways has dropped below 10,000 for the first time since 2011. ... in 2013. , According to data released by the National Highway Traffic Safety Administration ...
(Date:11/25/2015)... , ... November 25, 2015 , ... ... of philanthropic seniors, is resulting in a way for homeless people to have ... Schaumburg have launched a new initiative whereby they are repurposing plastic bags into ...
Breaking Medicine News(10 mins):